New Advances in Antithrombotic Therapy for Elderly Patients with Acute Coronary Syndrome
Abstract：Elderly acute coronary syndrome (ACS) mainly includes unstable angina pectoris, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction [1]. The occurrence of elderly ACS is related to multiple factors, such as atherosclerosis, hypertension, hyperlipidemia, diabetes, smoking, obesity, and genetic factors [2]. With aging, the vascular elasticity of the elderly decreases, and the progression of atherosclerosis accelerates, which can lead to coronary artery stenosis or occlusion, thereby causing acute myocardial ischemia [3]. The main long-term treatment is drug-based antithrombotic therapy, which can inhibit platelet aggregation and the activity of coagulation factors, reduce the risk of thrombosis, and maintain the patency of the coronary arteries to provide sufficient blood supply to the myocardium.
Machine-generated Keywords：
Publication Date：2025-08-20
Online Publishing Date：2025-10-24(First online date of this platform, not the publication date of the document)
Pages：3( 1022-1024 )